- Home
- ARBK vs BJDX Comparison
ARBK vs BJDX Comparison
Compare ARBK & BJDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ARBK | BJDX |
|---|---|---|
| Founded | 2017 | 2015 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3M | 1.2M |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ARBK | BJDX |
|---|---|---|
| Price | $4.05 | $0.70 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 314.1K | 135.5K |
| Earning Date | 05-01-2026 | 11-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $24,043,000.00 | N/A |
| Revenue This Year | $183.90 | N/A |
| Revenue Next Year | $26.78 | $55.56 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.25 | $0.63 |
| 52 Week High | $205.20 | $10.20 |
Technical Indicators
Market Signals| Indicator | ARBK | BJDX |
|---|---|---|
| Relative Strength Index (RSI) | 61.14 | 25.84 |
| Support Level | $3.30 | $0.63 |
| Resistance Level | $3.86 | $0.75 |
| Average True Range (ATR) | 0.77 | 0.08 |
| MACD | -0.13 | 0.01 |
| Stochastic Oscillator | 23.16 | 14.49 |
Price Performance
Historical ComparisonAbout ARBK Argo Blockchain plc
Argo Blockchain PLC is a blockchain technology company focused on the large-scale mining of Bitcoin. It mines bitcoin using purpose-built computers (or mining machines) to solve complex cryptographic algorithms on the blockchain in exchange for rewards and fees denominated in the native token of that blockchain network. The company acquires and deploys mining technology solutions in North American facilities that utilize predominantly renewable and inexpensive electricity.
About BJDX Bluejay Diagnostics Inc.
Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from 'sample-to-result' to help medical professionals make earlier and better triage/treatment decisions.